Literature DB >> 20010699

Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension.

Takahiro Naganuma1, Tomohiro Nakayama, Naoyuki Sato, Zhenyan Fu, Masayoshi Soma, Mai Yamaguchi, Masanori Shimodaira, Noriko Aoi, Ron Usami.   

Abstract

BACKGROUND: Oxidative DNA damage is involved in the pathophysiology of essential hypertension (EH), which is a multifactorial disorder. Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/REF-1) is an essential endonuclease in the base excision repair pathway of oxidatively damaged DNA, in addition to having reducing properties that promote the binding of redox-sensitive transcription factors. Blood pressure in APE1/REF-1-knockout mice is reported to be significantly higher than in wild-type mice. The aim of this study was to investigate the relationship between EH and the human APE1/REF-1 gene through a haplotype-based case-control study using single-nucleotide polymorphisms (SNPs).
METHODS: We selected five SNPs in the human APE1/REF-1 gene (rs1760944, rs3136814, rs17111967, rs3136817, and rs1130409), and performed case-control studies in 265 EH patients and 266 age-matched normotensive (NT) subjects.
RESULTS: rs17111967 was found to show nonheterogeneity among Japanese subjects. There were no significant differences in the overall distribution of genotypes or alleles for each SNP between EH and NT groups. In the overall distribution of the haplotype-based case-control study constructed based on rs1760944, rs3136817, and rs1130409, the frequency of the G-T-T haplotype was significantly higher in the EH group than in the NT group (2.1% vs. 0.0%, P = 0.001). Multiple logistic regression analysis also revealed significant differences for the G-T-T haplotype, even after adjustment for confounding factors (OR = 8.600, 95% CI: 1.073-68.951, P = 0.043).
CONCLUSIONS: Based on the present results, the G-T-T haplotype appears to be a genetic marker of EH, and the APE1/REF-1 gene appears to be a susceptibility gene for EH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010699     DOI: 10.1038/ajh.2009.221

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  A Case-Control Study of the APELA Gene and Hypertensive Disorders of Pregnancy.

Authors:  Naomi Shimada; Tomohiro Nakayama; Hiroshi Umemura; Kei Kawana; Tatsuo Yamamoto; Seisaku Uchigasaki
Journal:  Medicina (Kaunas)       Date:  2022-04-26       Impact factor: 2.948

2.  Haplotype-based, case-control study of the receptor (calcitonin) activity-modifying protein (RAMP) 1 gene in essential hypertension.

Authors:  T Nakayama; T Nakazato; H Naruse; Z Fu; Z Wang; M Soma; T Hoshino; M Shimodaira; N Aoi
Journal:  J Hum Hypertens       Date:  2017-02-09       Impact factor: 3.012

3.  Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo.

Authors:  Nina Queisser; Patricia I Oteiza; Samuel Link; Valentin Hey; Helga Stopper; Nicole Schupp
Journal:  Antioxid Redox Signal       Date:  2014-03-21       Impact factor: 8.401

Review 4.  Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.

Authors:  Sunga Choi; Hee Kyoung Joo; Byeong Hwa Jeon
Journal:  Chonnam Med J       Date:  2016-05-20

5.  Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis.

Authors:  Seon-Ah Jin; Byung-Kwan Lim; Hee Jung Seo; Sun Kyeong Kim; Kye Taek Ahn; Byeong Hwa Jeon; Jin-Ok Jeong
Journal:  Int J Mol Sci       Date:  2017-12-08       Impact factor: 5.923

Review 6.  The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders.

Authors:  Jenq-Lin Yang; Wei-Yu Chen; Shang-Der Chen
Journal:  Int J Mol Sci       Date:  2017-08-26       Impact factor: 5.923

7.  Elevation of the Serum Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 in Coronary Artery Disease.

Authors:  Seon-Ah Jin; Hee Jung Seo; Sun Kyeong Kim; Yu Ran Lee; Sunga Choi; Kye-Taek Ahn; Jun-Hyung Kim; Jae-Hyeong Park; Jae-Hwan Lee; Si Wan Choi; In-Whan Seong; Byeong Hwa Jeon; Jin-Ok Jeong
Journal:  Korean Circ J       Date:  2015-04-22       Impact factor: 3.243

Review 8.  APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.

Authors:  Shweta Thakur; Bibekananda Sarkar; Ravi P Cholia; Nandini Gautam; Monisha Dhiman; Anil K Mantha
Journal:  Exp Mol Med       Date:  2014-07-18       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.